1. Home
  2. CAKE vs DNLI Comparison

CAKE vs DNLI Comparison

Compare CAKE & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheesecake Factory Incorporated (The)

CAKE

Cheesecake Factory Incorporated (The)

HOLD

Current Price

$66.58

Market Cap

3.0B

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$21.05

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAKE
DNLI
Founded
1972
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
CAKE
DNLI
Price
$66.58
$21.05
Analyst Decision
Hold
Strong Buy
Analyst Count
16
14
Target Price
$60.31
$34.33
AVG Volume (30 Days)
1.1M
1.8M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.92%
N/A
EPS Growth
N/A
N/A
EPS
1.02
N/A
Revenue
$3,751,806,000.00
N/A
Revenue This Year
$6.14
N/A
Revenue Next Year
$6.65
$408.85
P/E Ratio
$63.24
N/A
Revenue Growth
4.75
N/A
52 Week Low
$43.07
$12.58
52 Week High
$69.70
$23.77

Technical Indicators

Market Signals
Indicator
CAKE
DNLI
Relative Strength Index (RSI) 65.96 61.34
Support Level $56.82 $17.99
Resistance Level $66.50 $22.07
Average True Range (ATR) 2.22 0.90
MACD 0.65 0.25
Stochastic Oscillator 93.99 96.25

Price Performance

Historical Comparison
CAKE
DNLI

About CAKE Cheesecake Factory Incorporated (The)

The Cheesecake Factory Inc is a restaurant company that owns and operates multiple casual dining brands across the United States and Canada under brands that include The Cheesecake Factory, North Italia, Flower Child, and additional brands within its Fox Restaurant Concepts portfolio. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, Other FRC, and Other. The majority of the company's revenue comes from the Cheesecake Factory restaurants segment.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: